Foster & Motley Inc. lowered its stake in MetLife, Inc. (NYSE:MET - Free Report) by 10.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 58,552 shares of the financial services provider's stock after selling 6,662 shares during the quarter. Foster & Motley Inc.'s holdings in MetLife were worth $4,794,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. United Asset Strategies Inc. raised its stake in shares of MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock valued at $895,000 after acquiring an additional 120 shares during the last quarter. Great Valley Advisor Group Inc. lifted its holdings in MetLife by 1.3% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider's stock worth $781,000 after buying an additional 123 shares during the period. Abacus Planning Group Inc. grew its position in shares of MetLife by 1.0% in the 3rd quarter. Abacus Planning Group Inc. now owns 12,301 shares of the financial services provider's stock worth $1,015,000 after buying an additional 127 shares during the last quarter. First Commonwealth Financial Corp PA increased its stake in shares of MetLife by 0.8% during the third quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider's stock valued at $1,375,000 after buying an additional 133 shares during the period. Finally, Avestar Capital LLC raised its holdings in shares of MetLife by 3.2% during the third quarter. Avestar Capital LLC now owns 4,264 shares of the financial services provider's stock valued at $352,000 after acquiring an additional 133 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company's stock.
MetLife Stock Performance
Shares of MET traded up $0.79 on Thursday, reaching $87.43. The company's stock had a trading volume of 820,757 shares, compared to its average volume of 3,457,529. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The stock has a market capitalization of $60.54 billion, a P/E ratio of 17.62, a PEG ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock's 50 day simple moving average is $84.03 and its two-hundred day simple moving average is $80.35.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.49%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio is presently 43.95%.
Wall Street Analysts Forecast Growth
MET has been the topic of a number of research analyst reports. Barclays boosted their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a research report on Monday, January 6th. Wells Fargo & Company reduced their target price on MetLife from $93.00 to $92.00 and set an "overweight" rating on the stock in a report on Tuesday, January 14th. BMO Capital Markets assumed coverage on MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target on the stock. Piper Sandler increased their price objective on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a report on Tuesday, January 7th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $90.46.
Check Out Our Latest Report on MET
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.